- Home
- Publications
- Publication Search
- Publication Details
Title
miRNAs as mediators of drug resistance
Authors
Keywords
-
Journal
Epigenomics
Volume 4, Issue 4, Pages 369-381
Publisher
Future Medicine Ltd
Online
2012-08-24
DOI
10.2217/epi.12.39
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- miR-181a sensitizes a multidrug-resistant leukemia cell line K562/A02 to daunorubicin by targeting BCL-2
- (2012) H. Li et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- Lysine-specific histone demethylase 1 (LSD1): A potential molecular target for tumor therapy
- (2012) Yingwei Chen et al. CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION
- Non-coding RNAs with essential roles in neurodegenerative disorders
- (2012) Evgenia Salta et al. LANCET NEUROLOGY
- MicroRNA profiling in K-562 cells under imatinib treatment
- (2012) Eleonora Turrini et al. Pharmacogenetics and Genomics
- MicroRNA-34a Modulates c-Myc Transcriptional Complexes to Suppress Malignancy in Human Prostate Cancer Cells
- (2012) Soichiro Yamamura et al. PLoS One
- The huge world of small RNAs: Regulating networks of microRNAs (Review)
- (2011) Zs. Rácz et al. ACTA PHYSIOLOGICA HUNGARICA
- MicroRNA-21 Modulates Chemosensitivity of Breast Cancer Cells to Doxorubicin by Targeting PTEN
- (2011) Zhao-Xia Wang et al. ARCHIVES OF MEDICAL RESEARCH
- miR-146a suppresses the sensitivity to interferon-α in hepatocellular carcinoma cells
- (2011) Akira Tomokuni et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Breast cancer resistance protein BCRP/ABCG2 regulatory microRNAs (hsa-miR-328, -519c and -520h) and their differential expression in stem-like ABCG2+ cancer cells
- (2011) Xin Li et al. BIOCHEMICAL PHARMACOLOGY
- Epigenetic inactivation of the MIR34B/C in multiple myeloma
- (2011) K. Y. Wong et al. BLOOD
- Addition of a histone deacetylase inhibitor redirects tamoxifen-treated breast cancer cells into apoptosis, which is opposed by the induction of autophagy
- (2011) Scott Thomas et al. BREAST CANCER RESEARCH AND TREATMENT
- miR-200bc/429 cluster modulates multidrug resistance of human cancer cell lines by targeting BCL2 and XIAP
- (2011) Wei Zhu et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Metformin Inhibits Cell Proliferation, Migration and Invasion by Attenuating CSC Function Mediated by Deregulating miRNAs in Pancreatic Cancer Cells
- (2011) B. Bao et al. Cancer Prevention Research
- MicroRNA Regulation of Cancer Stem Cells
- (2011) C. Liu et al. CANCER RESEARCH
- ID4 Imparts Chemoresistance and Cancer Stemness to Glioma Cells by Derepressing miR-9*-Mediated Suppression of SOX2
- (2011) H.-M. Jeon et al. CANCER RESEARCH
- Novel Histone Demethylase LSD1 Inhibitors Selectively Target Cancer Cells with Pluripotent Stem Cell Properties
- (2011) J. Wang et al. CANCER RESEARCH
- Epigenetic aberrations during oncogenesis
- (2011) Maria Hatziapostolou et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- MicroRNA-146a Downregulates NF B Activity via Targeting TRAF6 and Functions as a Tumor Suppressor Having Strong Prognostic Implications in NK/T Cell Lymphoma
- (2011) J. H. Paik et al. CLINICAL CANCER RESEARCH
- Reduced miR-128 in Breast Tumor-Initiating Cells Induces Chemotherapeutic Resistance via Bmi-1 and ABCC5
- (2011) Y. Zhu et al. CLINICAL CANCER RESEARCH
- Epigenetics and chemoresistance in colorectal cancer: An opportunity for treatment tailoring and novel therapeutic strategies
- (2011) Francesco Crea et al. DRUG RESISTANCE UPDATES
- The early life social environment and DNA methylation
- (2011) Moshe Szyf Epigenetics
- The Suv39H1 methyltransferase inhibitor chaetocin causes induction of integrated HIV-1 without producing a T cell response
- (2011) Wendy Bernhard et al. FEBS LETTERS
- RNA-directed epigenomic reprogramming-an emerging principle of a more targeted cancer therapy?
- (2011) Evgeny A. Moskalev et al. GENES CHROMOSOMES & CANCER
- Circulating microRNAs as potential markers of human drug-induced liver injury
- (2011) Philip J. Starkey Lewis et al. HEPATOLOGY
- Up-regulation ofmiR-21Mediates Resistance to Trastuzumab Therapy for Breast Cancer
- (2011) Chang Gong et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Repression of tumor suppressor miR-451 is essential for NOTCH1-induced oncogenesis in T-ALL
- (2011) Xiaoyu Li et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Histone acetylation-mediated glycosyltransferase gene regulation in mouse brain during development
- (2011) Yusuke Suzuki et al. JOURNAL OF NEUROCHEMISTRY
- Anti-leukemia activity of chaetocin via death receptor-dependent apoptosis and dual modulation of the histone methyl-transferase SUV39H1
- (2011) H Chaib et al. LEUKEMIA
- miR-497 modulates multidrug resistance of human cancer cell lines by targeting BCL2
- (2011) Wei Zhu et al. MEDICAL ONCOLOGY
- Non-coding RNAs in cancer initiation and progression and as novel biomarkers
- (2011) S. Patrick Nana-Sinkam et al. Molecular Oncology
- Down-Regulation of ATP-Binding Cassette C2 Protein Expression in HepG2 Cells after Rifampicin Treatment Is Mediated by MicroRNA-379
- (2011) S. Haenisch et al. MOLECULAR PHARMACOLOGY
- Inhibition of LSD1 sensitizes glioblastoma cells to histone deacetylase inhibitors
- (2011) M. M. Singh et al. NEURO-ONCOLOGY
- A Pilot Phase II Study of Valproic Acid for Treatment of Low-Grade Neuroendocrine Carcinoma
- (2011) T. A. Mohammed et al. ONCOLOGIST
- Down-Regulation of miR-101 in Endothelial Cells Promotes Blood Vessel Formation through Reduced Repression of EZH2
- (2011) Michiel Smits et al. PLoS One
- Targeting Epigenetic Regulation of miR-34a for Treatment of Pancreatic Cancer by Inhibition of Pancreatic Cancer Stem Cells
- (2011) Dara Nalls et al. PLoS One
- MicroRNAs in the Pathogenesis of Cancer
- (2011) Francesca Lovat et al. SEMINARS IN ONCOLOGY
- Frequent concomitant inactivation of miR-34a and miR-34b/c by CpG methylation in colorectal, pancreatic, mammary, ovarian, urothelial, and renal cell carcinomas and soft tissue sarcomas
- (2011) Markus Vogt et al. VIRCHOWS ARCHIV
- Combination Epigenetic Therapy Has Efficacy in Patients with Refractory Advanced Non-Small Cell Lung Cancer
- (2011) R. A. Juergens et al. Cancer Discovery
- Embryonic Stem Cell MicroRNAs: Defining Factors in Induced Pluripotent (iPS) and Cancer (CSC) Stem Cells?
- (2011) Preethi Gunaratne Current Stem Cell Research & Therapy
- Viruses, microRNAs, and Host Interactions
- (2010) Rebecca L. Skalsky et al. Annual Review of Microbiology
- The involvement of microRNAs in Type 2 diabetes
- (2010) David Ferland-McCollough et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- miR-328 Functions as an RNA Decoy to Modulate hnRNP E2 Regulation of mRNA Translation in Leukemic Blasts
- (2010) Anna M. Eiring et al. CELL
- Valproate-doxorubicin: promising therapy for progressing mesothelioma. A phase II study
- (2010) A. Scherpereel et al. EUROPEAN RESPIRATORY JOURNAL
- Involvement of miR-21 in resistance to daunorubicin by regulating PTEN expression in the leukaemia K562 cell line
- (2010) Haitao Bai et al. FEBS LETTERS
- MiR-27a modulates MDR1/P-glycoprotein expression by targeting HIPK2 in human ovarian cancer cells
- (2010) Zhimin Li et al. GYNECOLOGIC ONCOLOGY
- Alterations of microRNAs and their targets are associated with acquired resistance of MCF-7 breast cancer cells to cisplatin
- (2010) Igor P. Pogribny et al. INTERNATIONAL JOURNAL OF CANCER
- miR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines
- (2010) Wei Zhu et al. INTERNATIONAL JOURNAL OF CANCER
- Down-regulated miR-331-5p and miR-27a are associated with chemotherapy resistance and relapse in leukaemia
- (2010) Dan-Dan Feng et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- A coding-independent function of gene and pseudogene mRNAs regulates tumour biology
- (2010) Laura Poliseno et al. NATURE
- Targeting microRNAs in cancer: rationale, strategies and challenges
- (2010) Ramiro Garzon et al. NATURE REVIEWS DRUG DISCOVERY
- Epigenetic phenomena linked to diabetic complications
- (2010) Luciano Pirola et al. Nature Reviews Endocrinology
- Histone H1 null vertebrate cells exhibit altered nucleosome architecture
- (2010) Hideharu Hashimoto et al. NUCLEIC ACIDS RESEARCH
- MicroRNA-221/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathways
- (2010) X Rao et al. ONCOGENE
- Epigenetics in neurodegeneration: A new layer of complexity
- (2010) Sueli C.F. Marques et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- MiR-34a attenuates paclitaxel-resistance of hormone-refractory prostate cancer PC3 cells through direct and indirect mechanisms
- (2010) Keitaro Kojima et al. PROSTATE
- Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1
- (2009) Zhongxing Liang et al. BIOCHEMICAL PHARMACOLOGY
- Gene silencing of MIR22 in acute lymphoblastic leukaemia involves histone modifications independent of promoter DNA methylation
- (2009) Xiaoqing Li et al. BRITISH JOURNAL OF HAEMATOLOGY
- MicroRNA-34a Inhibits Glioblastoma Growth by Targeting Multiple Oncogenes
- (2009) Y. Li et al. CANCER RESEARCH
- Epigenetics in cancer
- (2009) S. Sharma et al. CARCINOGENESIS
- Downregulation of miRNA-200c Links Breast Cancer Stem Cells with Normal Stem Cells
- (2009) Yohei Shimono et al. CELL
- Down-Regulation of miR-27a Might Reverse Multidrug Resistance of Esophageal Squamous Cell Carcinoma
- (2009) Hongwei Zhang et al. DIGESTIVE DISEASES AND SCIENCES
- Escape from hsa-miR-519c enables drug-resistant cells to maintain high expression of ABCG2
- (2009) K. K.W. To et al. MOLECULAR CANCER THERAPEUTICS
- MicroRNA-328 Negatively Regulates the Expression of Breast Cancer Resistance Protein (BCRP/ABCG2) in Human Cancer Cells
- (2009) Y.-Z. Pan et al. MOLECULAR PHARMACOLOGY
- Antipsychotic subtypes can be characterized by differences in their ability to modify GABAergic promoter methylation
- (2009) Erbo Dong et al. Epigenomics
- Epigenetics, DNA Methylation, and Chromatin Modifying Drugs
- (2008) Moshe Szyf Annual Review of Pharmacology and Toxicology
- Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells
- (2008) Hua Zhu et al. BIOCHEMICAL PHARMACOLOGY
- miR-34a as part of the resistance network in chronic lymphocytic leukemia
- (2008) T. Zenz et al. BLOOD
- Genetic and Epigenetic Silencing of MicroRNA-203 Enhances ABL1 and BCR-ABL1 Oncogene Expression
- (2008) María J. Bueno et al. CANCER CELL
- miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells
- (2008) Lin Xia et al. INTERNATIONAL JOURNAL OF CANCER
- MicroRNA-221/222 Negatively Regulates Estrogen Receptorα and Is Associated with Tamoxifen Resistance in Breast Cancer
- (2008) Jian-Jun Zhao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MicroRNA-221/222 Confers Tamoxifen Resistance in Breast Cancer by Targeting p27Kip1
- (2008) Tyler E. Miller et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MicroRNAs play a role in the development of human hematopoietic stem cells
- (2008) Rongxia Liao et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Regulation of ABCG2 Expression at the 3' Untranslated Region of Its mRNA through Modulation of Transcript Stability and Protein Translation by a Putative MicroRNA in the S1 Colon Cancer Cell Line
- (2008) K. K. W. To et al. MOLECULAR AND CELLULAR BIOLOGY
- Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin
- (2008) O. Kovalchuk et al. MOLECULAR CANCER THERAPEUTICS
- Evidence for Selective microRNAs and Their Effectors as Common Long-Term Targets for the Actions of Mood Stabilizers
- (2008) Rulun Zhou et al. NEUROPSYCHOPHARMACOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started